WAUKEGAN, Ill.--(BUSINESS WIRE)--NEOPHARM, Inc. (Nasdaq:NEOL): 2006 third-quarter net loss reduced 24% to $8.0 million vs. prior year quarter Third-quarter cash use reduced 35% to $5.4 million vs. prior year quarter Company reduces full-year 2006 expense guidance
